12-Nitro-camptothecin
Latest Information Update: 21 Oct 1997
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Camptothecins
- Mechanism of Action DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 21 Oct 1997 No-Development-Reported for Cancer in USA (Unknown route)